Sonia Rouatbi
University of Sousse
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sonia Rouatbi.
Libyan Journal of Medicine | 2014
Syrine Ben Moussa; Ines Sfaxi; Zouhair Tabka; Helmi Ben Saad; Sonia Rouatbi
Background The mechanisms of smoking tobacco leading to chronic obstructive pulmonary disease (COPD) are beginning to be understood. However, conclusions about the role of blood or lung oxidative stress markers were disparate. Aims To investigate the oxidative stress in blood or lung associated with tobacco smoke and to evaluate its effect on pulmonary function data and its relation with physical activity. Methods It is a case-control study. Fifty-four male-smokers of more than five pack-years (PY) and aged 40-60 years were included (29 Non-COPD, 16 COPD). Physical activity score was determined. Blood sample levels of malondialdehyde (MDA), protein-cys-SH (PSH), and Glutathione (GSH) were measured. Fractional exhaled nitric oxide (FeNO) and plethysmographic measurements were performed. Correlation coefficients (r) evaluated the association between oxidative stress markers and independent variables (plethysmographic data and physical activity score). Results Non-COPD (48±6 years) and COPD (49±5 years) groups had similar tobacco consumption patterns, that is, 27±14 PY versus 30±19 PY, respectively. Compared to the Non-COPD group, the COPD group had significantly lower levels of GSH and PSH, that is, mean±SE were 40±6 versus 25±5 µg/mL and 54±10 versus 26±5 µg/g of hemoglobin, respectively. However, MDA level and FeNO values were similar. In the COPD group, none of the oxidative stress markers was significantly correlated with plethysmographic data or physical activity score. In the Non-COPD group, GSH was significantly correlated with physical activity score (r=0.47) and PSH was significantly correlated with total lung capacity (TLC) (r=-0.50), residual volume (r=0.41), and physical activity score (r=0.62). FeNO was significantly correlated with TLC of the COPD group (r=-0.48). Conclusion Compared to the Non-COPD group, the COPD group had a marked decrease in blood antioxidant markers (GSH and PSH) but similar blood oxidant (MDA) or lung (FeNO) burden.Background The mechanisms of smoking tobacco leading to chronic obstructive pulmonary disease (COPD) are beginning to be understood. However, conclusions about the role of blood or lung oxidative stress markers were disparate. Aims To investigate the oxidative stress in blood or lung associated with tobacco smoke and to evaluate its effect on pulmonary function data and its relation with physical activity. Methods It is a case-control study. Fifty-four male-smokers of more than five pack-years (PY) and aged 40–60 years were included (29 Non-COPD, 16 COPD). Physical activity score was determined. Blood sample levels of malondialdehyde (MDA), protein-cys-SH (PSH), and Glutathione (GSH) were measured. Fractional exhaled nitric oxide (FeNO) and plethysmographic measurements were performed. Correlation coefficients (r) evaluated the association between oxidative stress markers and independent variables (plethysmographic data and physical activity score). Results Non-COPD (48±6 years) and COPD (49±5 years) groups had similar tobacco consumption patterns, that is, 27±14 PY versus 30±19 PY, respectively. Compared to the Non-COPD group, the COPD group had significantly lower levels of GSH and PSH, that is, mean±SE were 40±6 versus 25±5 µg/mL and 54±10 versus 26±5 µg/g of hemoglobin, respectively. However, MDA level and FeNO values were similar. In the COPD group, none of the oxidative stress markers was significantly correlated with plethysmographic data or physical activity score. In the Non-COPD group, GSH was significantly correlated with physical activity score (r=0.47) and PSH was significantly correlated with total lung capacity (TLC) (r=−0.50), residual volume (r=0.41), and physical activity score (r=0.62). FeNO was significantly correlated with TLC of the COPD group (r=−0.48). Conclusion Compared to the Non-COPD group, the COPD group had a marked decrease in blood antioxidant markers (GSH and PSH) but similar blood oxidant (MDA) or lung (FeNO) burden.
Respiratory Care | 2014
Helmi Ben Saad; Maya Babba; Rafik Boukamcha; Ines Ghannouchi; Imed Latiri; Sonia Mezghenni; Chakib Zedini; Sonia Rouatbi
BACKGROUND: Studies on the submaximal aerobic capacity of exclusive narghile smokers (ENS) seem necessary in view of effective prevention of cardiorespiratory diseases. The goal of the study was to assess, by 6-min walk test (6MWT) data, the submaximal aerobic capacity of ENS, to identify factors influencing their 6-min walk distance (6MWD), and to compare their data with those of a healthy non-smoker (HNS) group. METHODS: Seventy 20–60-y-old male ENS were included. Narghile use (narghile-years) and anthropometric, clinical, spirometric, and 6MWT data were collected. Univariate and multivariate analyses were used to identify factors influencing 6MWD. Data of a subgroup of 40–60-y-old ENS (n = 25) were compared with those of an age-matched HNS group (n = 53). RESULTS: The median (first to third quartile) for age and narghile use were 32 (26–43) and 17 (8–32) narghile-years, respectively. The profile of ENS performing the 6MWT was as follows: at the end of the 6MWT, 34% and 9% had a low heart rate (< 60% of maximum predicted) and high dyspnea scores (> 5/10, visual analog scale), respectively; 3% had an oxyhemoglobin saturation decrease of > 5 points during the test; and 20% had an abnormal 6MWD (less than the lower limit of the normal range). The factors that significantly influenced the 6MWD, explaining 38% of its variability, are included in the following equation: 6MWD (m) = 742.63 − 5.20 × body mass index (kg/m2) + 25.23 × FEV1 (L) − 0.44 × narghile use (narghile-years). Compared with HNS, the subgroup of ENS had a significantly lower 6MWD (98 ± 7 vs 87 ± 9% predicted, respectively). CONCLUSIONS: Narghile use may play a role in reducing submaximal aerobic capacity. The present study suggests that a program of pulmonary rehabilitation is an excellent axis to follow.
Libyan Journal of Medicine | 2013
Helmi Ben Saad; M. Khemiss; Saida Nhari; Mejda Ben Essghaier; Sonia Rouatbi
Background Studies of the lung function profiles of exclusive narghile smokers (ENS) are few, have some methodological limits, and present contradictory conclusions. The present study aimed to compare the plethysmographic profiles of ENS with age- and height-matched exclusive cigarette smokers (ECS). Methods Males aged 35–60 living in Sousse, Tunisia, who have been smoking narghile exclusively for more than 10 narghile-years (n = 36) or cigarettes exclusively for more than 10 pack-years (n = 106) were recruited to participate in this case–control study. The anthropometric and plethysmographic data were measured according to international recommendations using a body plethysmograph (ZAN 500 Body II, Meβgreräte GmbH, Germany). Large-airway-obstructive-ventilatory-defect (LAOVD) was defined as: first second forced expiratory volume/forced vital capacity (FEV1/FVC) below the lower-limit-of-normal (LLN). Restrictive-ventilatory-defect (RVD) was defined as total lung capacity < LLN. Lung hyperinflation was defined as residual volume > upper-limit-of-normal. Student t-test and χ2 test were used to compare plethysmographic data and profiles of the two groups. Results The subjects in the ENS and ECS groups are well matched in age (45±7 vs. 47±5 years) and height (1.73±0.06 vs. 1.72±0.06 m) and used similar quantities of tobacco (36±22 narghile-years vs. 35±19 pack-years). Compared to the ENS group, the ECS group had significantly lower FEV1 (84±12 vs. 60±21%), FVC (90±12 vs. 76±18%), and FEV1/FVC (99±7 vs. 83±17%). The two groups had similar percentages of RVD (31 vs. 36%), while the ECS group had a significantly higher percentage of LAOVD (8 vs. 58%) and lung hyperinflation (36 vs.57%). Conclusion Chronic exclusive narghile smoking has less adverse effects on pulmonary function tests than chronic exclusive cigarette smoking.Background Studies of the lung function profiles of exclusive narghile smokers (ENS) are few, have some methodological limits, and present contradictory conclusions. The present study aimed to compare the plethysmographic profiles of ENS with age- and height-matched exclusive cigarette smokers (ECS). Methods Males aged 35-60 living in Sousse, Tunisia, who have been smoking narghile exclusively for more than 10 narghile-years (n = 36) or cigarettes exclusively for more than 10 pack-years (n = 106) were recruited to participate in this case-control study. The anthropometric and plethysmographic data were measured according to international recommendations using a body plethysmograph (ZAN 500 Body II, Meβgreräte GmbH, Germany). Large-airway-obstructive-ventilatory-defect (LAOVD) was defined as: first second forced expiratory volume/forced vital capacity (FEV1/FVC) below the lower-limit-of-normal (LLN). Restrictive-ventilatory-defect (RVD) was defined as total lung capacity < LLN. Lung hyperinflation was defined as residual volume > upper-limit-of-normal. Student t-test and χ2 test were used to compare plethysmographic data and profiles of the two groups. Results The subjects in the ENS and ECS groups are well matched in age (45±7 vs. 47±5 years) and height (1.73±0.06 vs. 1.72±0.06 m) and used similar quantities of tobacco (36±22 narghile-years vs. 35±19 pack-years). Compared to the ENS group, the ECS group had significantly lower FEV1 (84±12 vs. 60±21%), FVC (90±12 vs. 76±18%), and FEV1/FVC (99±7 vs. 83±17%). The two groups had similar percentages of RVD (31 vs. 36%), while the ECS group had a significantly higher percentage of LAOVD (8 vs. 58%) and lung hyperinflation (36 vs.57%). Conclusion Chronic exclusive narghile smoking has less adverse effects on pulmonary function tests than chronic exclusive cigarette smoking.
Revue Des Maladies Respiratoires | 2006
Sonia Rouatbi; Y.F. Ouahchi; C. Ben Salah; H. Ben Saad; I. Harrabi; Zouhair Tabka; Hervé Guénard
Resume Introduction Le poumon subit plusieurs modifications physiologiques au cours de la vie. L’objectif de ce travail est d’identifier les facteurs qui peuvent influencer la fonction du poumon profond en etudiant la diffusion membranaire (Dm) et le volume sanguin capillaire pulmonaire (Vc). Methodes Une mesure de la Dm et du Vc a ete realisee au repos chez 135 sujets sains repartis en 3 groupes d’âges differents. Les memes mesures ont ete effectuees apres une epreuve d’exercice musculaire chez 22 enfants. La technique de mesure impliquait le transfert simultane de 2 gaz, le monoxyde d’azote (NO) et le monoxyde de carbone (CO). Resultats La Dm est correlee a la taille chez le groupe adulte et au poids chez les âges. Vc n’est pas correle au poids chez les trois groupes etudies, mais il l’est avec la taille chez les adultes jeunes. Dm et Vc diminuent significativement avec l’âge (p Conclusion La connaissance de toutes ces modifications physiologiques permettra une meilleure interpretation des variations pathologiques de la fonction du poumon profond.
Libyan Journal of Medicine | 2014
Mohamed Amine Fenneni; Imed Latiri; Asma Aloui; Sonia Rouatbi; Mohamed Ali Saafi; I. Bougmiza; Karim Chamari; Helmi Ben Saad
Introduction Most of the literature related to the effects of Ramadan fasting on physical performance has focused on adults, and only three studies have examined its impact on childrens physical performance. Aims To examine the effects of Ramadan fasting on first-time fasting boys’ performance in short-term explosive exercises [vertical and horizontal jump tests (VJT and HJT), 20-m and 30-m sprints and medicine-ball throw (MBT)], as well as in sub-maximal endurance [6-min walking distance (6MWD) measured during the 6-min walk test (6MWT)]. Methods Eighteen Tunisian boys [mean±standard deviation (SD) of age and body mass (BM): 11.9±0.8 y and 55.4±18.2 kg, respectively] were included. The experimental design comprised four testing phases: 2-weeks before Ramadan (BR), the end of the second week (R2) and the fourth week (R4) of Ramadan, and 10–12 days after the end of Ramadan (AR). At each phase, boys performed two test sessions in the afternoon (15:00–17:00 h) interrupted by 48 h of recovery (first test session: BM, VJT, HJT, and 20-m and 30-m sprint tests; second session: MBT and 6MWT). The study was conducted during the summer of 2012 from July 5 to August 29. Results 6MWDs (m) were significantly shorter during R2 (652±101) and R4 (595±123) compared to BR (697±86) and came back to baseline values AR. BM (kg) mean±SD did not significantly change during R2 (52±15) and during R4 (53±15) compared to BR (55±17), and short-term explosive performances were unchanged throughout the study. Conclusion In non-athletic children, first-ever Ramadan fasting impairs sub-maximal aerobic capacity but has no effect on BM or short-term explosive performance.
Respiration | 2010
Sonia Rouatbi; Helmi Ben Saad; Imed Latiri; Zouhair Tabka; Hervé Guénard
Background: In North-African adults, location-specific reference values for membrane diffusion capacity (D<sub>m</sub>) and pulmonary capillary blood volume (V<sub>c</sub>) were needed. Objectives: To verify the applicability of previously published reference equations for D<sub>m</sub> and V<sub>c</sub> in North-African healthy adults (age >18 years) and to determine specific reference equations for North Africa. Methods: The study was designed as a prospective cross-sectional study. Anthropometric data (age, height, weight and body mass index) and D<sub>m</sub> and V<sub>c</sub> were assessed in 85 healthy Tunisian adults. Univariate and multiple linear regression analyses were used to determine reference equations and to calculate the lower limit of the normal range (LLN). Results: The mean ages ± SD (minimum – maximum) for male and female adults were 53 ± 21 (21–85) and 42 ± 16 (18–72) years, respectively. Previously published reference equations did not reliably predict measured D<sub>m</sub> and V<sub>c</sub>. The reference equation (r<sup>2</sup> = 47%) for D<sub>m</sub> was –36.16 + 45.37 × height – 0.34 × age + 0.39 × weight + 7.41 × gender (0 = female and 1 = male). To calculate the D<sub>m</sub> LLN subtract 24.36 from the reference value. The reference equation (r<sup>2</sup> = 30%) for female V<sub>c</sub> was 94.70 – 0.57 × age, and the reference equation (r<sup>2</sup> = 52%) for male V<sub>c</sub> was 0.82 – 0.48 × age + 52.47 × height + 0.16 × weight. To calculate the V<sub>c</sub> LLN subtract 28.52 and 26.54 from these reference values for females and males, respectively. Conclusion: These V<sub>c</sub> and D<sub>m</sub> reference equations supplement the international World Bank of reference equations.
Revue Des Maladies Respiratoires | 2007
H. Ben Saad; R Ben Attia Saafi; Sonia Rouatbi; S. Ben Mdella; A. Garrouche; A. Zbidi; Maurice Hayot; Zouhair Tabka
Resume Introduction Il n’existe pas de consensus clair en ce qui constitue un deficit ventilatoire obstructif (DVO). Selon l’ American Thoracic Society et l’ European Respiratory Society , c’est un rapport entre le volume expiratoire force seconde (VEMS) et la capacite vitale lente (CV) Global initiative for chronic Obstructive Lung Disease ou le British Thoracic Society, c’est un rapport VEMS/capacite vitale expiratoire forcee (CVF) Methodes Un questionnaire medical est realise. Les donnees anthropometriques sont determinees. Les debits expiratoires et les volumes pulmonaires sont mesures a l’aide d’un plethysmographe. Resultats Cent vingt et un (81 %) hommes parmi les 150 adresses sont inclus. Le pourcentage des hommes ayant un DVO est de 56,1 % (VEMS/CV Conclusion Le deficit ventilatoire obstructif est recommandation dependant.
Respiratory Physiology & Neurobiology | 2002
Weimin Zhao; Sonia Rouatbi; Zouhair Tabka; Hervé Guénard
The study was conducted to characterize the action of NaF, which had relaxing property in carbachol precontracted isolated bovine bronchus, on airway responsiveness challenged by acetylcholine receptor agonists in rats and asthmatic humans. Tracheal flow rate and airway resistance were measured in anaesthetized rats. NaF was delivered either before carbachol challenge or together with carbachol. Patients with mild asthma were challenged with methacholine aerosol, and NaF was delivered when FEV1 fell by more than 20%. The results indicated that: (1) in rats NaF significantly inhibited carbachol-induced bronchial constriction when inhaled prior to carbachol challenge as airway resistances in the NaF and NaF+verapamil groups were significantly lower than those in the control group; (2) NaF significantly reversed carbachol or methacholine-induced bronchial constriction in asthmatic patients. In conclusion, NaF, delivered in form of aerosol, reduced bronchial responsiveness to carbachol in rats and had a bronchodilating effect on rat and human airways precontracted by inhalation of acetylcholine analogs.
Libyan Journal of Medicine | 2015
Mohamed Amine Fenneni; Imed Latiri; Asma Aloui; Sonia Rouatbi; Karim Chamari; Helmi Ben Saad
No abstract available. (Published: 8 June 2015) Citation: Libyan J Med 2015, 10 : 28351 -http://dx.doi.org/10.3402/ljm.v10.28351
BioMed Research International | 2014
Sonia Rouatbi; Mohamed Ali Chouchène; Ines Sfaxi; Mohamed Ben Rejeb; Zouhair Tabka; Helmi Ben Saad
Aims. To establish FeNO norms for healthy Tunisian adults aged 18–60 years and to prospectively assess their reliability. Methods. This was a cross-sectional analytical study. A convenience sample of healthy Tunisian adults was recruited. Subjects responded to a medical questionnaire, and then FeNO levels were measured by an online method (Medisoft, Sorinnes (Dinant), Belgium). Clinical, anthropometric, and plethysmographic data were collected. All analyses were performed on natural logarithm values of FeNO. Results. 257 adults (145 males) were retained. The proposed reference equation to predict FeNO value is lnFeNO (ppb) = 3.47−0.56× height (m). After the predicted FeNO value for a given adult was computed, the upper limit of normal could be obtained by adding 0.60 ppb. The mean ± SD (minimum-maximum) of FeNO (ppb) for the total sample was 13.54 ± 4.87 (5.00–26.00). For Tunisian and Arab adults of any age and height, any FeNO value greater than 26.00 ppb may be considered abnormal. Finally, in an additional group of adults prospectively assessed, we found no adult with a FeNO higher than 26.00 ppb. Conclusion. The present FeNO norms enrich the global repository of FeNO norms that the clinician can use to choose the most appropriate norms.